Efficacy and Safety of Sugammadex in Renal Diseased Patients
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether sugammadex reverses a profound
neuromuscular blockade induced by rocuronium in patients with end-stage renal disease just as
effectively and safely as it does in patients with normal renal function.